PubMed · 1991 · 23 citations · 23 references
Chemoprevention StrategyLow DoseOncogenic AgentMedicinePhenolic AntioxidantsRat Forestomach CarcinogenesisPathologyCancer PreventionToxicologyLow Dose CombinationTwo-stage Forestomach CarcinogenesisMetabolomicsForestomach CarcinogenesisPharmacologyRadiation OncologyCancer ResearchPolyphenolicsOxidative Stress
The combined effects of low doses of promoters or carcinogens on two-stage forestomach carcinogenesis were examined in rats pretreated with N-methyl-N'-nitro-N-nitrosoguanidine. Groups of 15 rats were given a single 150 mg/kg body weight intragastric dose of N-methyl-N'-nitro-N-nitrosoguanidine. Starting 1 week later they were fed a diet containing low doses of known forestomach promoters/carcinogens (0.5% caffeic acid, 0.2% catechol, 0.5% butylated hydroxyanisole, or 0.25% 2-tert-butyl-4-methylphenol), alone or in combination, or basal diet without antioxidant supplement for 35 weeks. Histopathological examination revealed the incidences of forestomach squamous cell carcinomas in animals treated with N-methyl-N'-nitro-N-nitrosoguanidine followed by caffeic acid, catechol, butylated hydroxyanisole, 2-tert-butyl-4-methylphenol, and basal diet to be 27, 20, 13, 13, and 7%, respectively, whereas the incidence increased to 80% by the combined treatment with these four chemicals. The present results thus show that although the low doses of individual promoters/carcinogens did not have significant promoting activity, their combination exerted a strong enhancing influence on rat forestomach carcinogenesis. The findings indicate the importance of summation and synergism at a low dose for agents present in the human environment.
23
N. Ito, Shoji Fukushima, Seiko Tamano et al. · JNCI Journal of the National Cancer Institute · 1986 · 79 citations
S Fukushima, M Ohshima, Atsuko Masuda et al. · JNCI Journal of the National Cancer Institute · 1984 · 72 citations
Katsumi Imaida, Shoji Fukushima, Tomoyuki Shirai et al. · PubMed · 1984 · 67 citations
Forestomach Carcinogenesis, Urology, Chemoprevention Strategy +11